Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
(NASDAQ:IMVT),(NASDAQ:ROIV), DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the third quarter ended December 31, 2025, and provide a business update at 8:00 a.m. ET on Friday, February 6, 2026. To access the Roivant (Nasdaq: ROIV) conference call by […]